Pain medications are essential for improving the care and outcomes for the 100 million adults living with chronic pain in the United States.
Ensysce Biosciences’ proprietary abuse-resistant opioid prodrug technology – the BIO-MD™ platform – is designed to improve the care of patients with chronic pain while reducing the human and economic costs associated with prescription opioid drug abuse.
The Multi-Pill Abuse Resistant (MPAR™) technology is unique to the industry and is designed not only to overcome abuse but to save lives.
BIO-MD™ abuse-resistant prodrugs and MPAR™ combination products have the potential to meet the medical needs of patients, while providing a solution to the national epidemic of prescription drug abuse.
Site |
Badges |
|
Ensysce Biosciences
3210 Merryfield Row
San Diego, CA, 92121
United States
|
|